Alcohol may be less harmful for people over 50

| February 28, 2019

article image
A recent study examines the health impact of consuming alcohol at different ages. The authors conclude that, for people over the age of 50, health risks may be less severe. Heavy drinking is linked to a range of serious health consequences. These include certain cancers, liver and heart disease, and damage to the nervous system, including the brain. However, as has been exhaustively covered in the popular press, drinking in moderation might have certain health benefits.

Spotlight

Genetics Society of America

The mission of the Genetics Society of America (GSA) is to deepen our understanding of the living world by advancing the field of genetics. It does this by: Fostering an international community of geneticists by promoting interaction among geneticists (including microbial, plant, animal, human, and population and theoretical geneticists) while cultivating a community of thought leaders in the field. Ensuring genetics fulfills its potential for broad impact by facilitating the application of genetic tools and approaches in biological research.

OTHER ARTICLES

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | April 17, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Comparing HydroxyChloroquine Trials

Article | April 1, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Spotlight

Genetics Society of America

The mission of the Genetics Society of America (GSA) is to deepen our understanding of the living world by advancing the field of genetics. It does this by: Fostering an international community of geneticists by promoting interaction among geneticists (including microbial, plant, animal, human, and population and theoretical geneticists) while cultivating a community of thought leaders in the field. Ensuring genetics fulfills its potential for broad impact by facilitating the application of genetic tools and approaches in biological research.

Events